WO2002032283A3 - Methods of and pharmaceutical compositions for improving implantation of embryos - Google Patents

Methods of and pharmaceutical compositions for improving implantation of embryos Download PDF

Info

Publication number
WO2002032283A3
WO2002032283A3 PCT/IL2001/000950 IL0100950W WO0232283A3 WO 2002032283 A3 WO2002032283 A3 WO 2002032283A3 IL 0100950 W IL0100950 W IL 0100950W WO 0232283 A3 WO0232283 A3 WO 0232283A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
embryos
pharmaceutical compositions
improving implantation
improving
Prior art date
Application number
PCT/IL2001/000950
Other languages
French (fr)
Other versions
WO2002032283A2 (en
Inventor
Oron Yacoby-Zeevi
Original Assignee
Insight Strategy And Marketing
Oron Yacoby-Zeevi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Strategy And Marketing, Oron Yacoby-Zeevi filed Critical Insight Strategy And Marketing
Priority to EP01978796A priority Critical patent/EP1333862A4/en
Priority to AU2002210887A priority patent/AU2002210887A1/en
Publication of WO2002032283A2 publication Critical patent/WO2002032283A2/en
Publication of WO2002032283A3 publication Critical patent/WO2002032283A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods of improving embryo implantation are disclosed and comprise contacting a receptive uterus and/or an embryo with an effective amount of heparanase and implanting the embryo in the receptive uterus.
PCT/IL2001/000950 2000-10-17 2001-10-15 Methods of and pharmaceutical compositions for improving implantation of embryos WO2002032283A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01978796A EP1333862A4 (en) 2000-10-17 2001-10-15 Methods of and pharmaceutical compositions for improving implantation of embryos
AU2002210887A AU2002210887A1 (en) 2000-10-17 2001-10-15 Methods of and pharmaceutical compositions for improving implantation of embryos

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24085700P 2000-10-17 2000-10-17
US60/240,857 2000-10-17

Publications (2)

Publication Number Publication Date
WO2002032283A2 WO2002032283A2 (en) 2002-04-25
WO2002032283A3 true WO2002032283A3 (en) 2002-10-31

Family

ID=22908221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2001/000950 WO2002032283A2 (en) 2000-10-17 2001-10-15 Methods of and pharmaceutical compositions for improving implantation of embryos

Country Status (3)

Country Link
EP (1) EP1333862A4 (en)
AU (1) AU2002210887A1 (en)
WO (1) WO2002032283A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
JP2005500977A (en) * 2000-12-19 2005-01-13 インサイト ストラテジー アンド マーケティング リミテッド Use of extracellular matrix degrading enzymes to improve cell transplantation
CN100384481C (en) * 2004-11-03 2008-04-30 上海市计划生育科学研究所 Blastocyst implantation related factor and its uses
CN100415299C (en) * 2004-12-22 2008-09-03 上海市计划生育科学研究所 Correlation factor of blastocyst nidation and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968822A (en) * 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3188691B2 (en) * 1989-08-23 2001-07-16 ハダサ メディカル オーガナイゼーション Wound healing composition containing heparanase
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US6242238B1 (en) * 1997-10-28 2001-06-05 The Australian National University Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968822A (en) * 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KIZAKI K. ET AL.: "Expression of heparanase mRNA in bovine placenta during gestation", REPRODUCTION, vol. 121, 2001, pages 573 - 580, XP002951950 *
See also references of EP1333862A4 *

Also Published As

Publication number Publication date
EP1333862A4 (en) 2004-08-18
WO2002032283A2 (en) 2002-04-25
AU2002210887A1 (en) 2002-04-29
EP1333862A2 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
TW200603838A (en) Extended release biodegradable ocular implants
AU2085201A (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
DE60129998D1 (en) DEVICE FOR IMPLANTING IN BONE
WO2005065079A3 (en) Medical implants and fibrosis-inducing agents
ES2182919T3 (en) DEVICE FOR URINARY INCONTINENCE ..
DE60040998D1 (en) IMPLANTABLE PROSTHETIC VALVE FLAP
CA2414680A1 (en) Methods for treating inflammation-mediated conditions of the eye
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2512901A (en) Implant for the closing of defect openings in the body of a human or animal and a system for the placement of such an implant
AU2003303598A8 (en) Compositions, methods, and systems for inferring bovine breed
SE0300860L (en) Urinary incontinence organs and process for their preparation
ZA200106160B (en) Compositions and methods for treating cataracts.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
WO2002053063A3 (en) Urinary incontinence device
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU1359401A (en) Chemoreceptors in plant parasitic nematodes
MXPA02003232A (en) Compositions and methods for altering gene expression.
ATE445426T1 (en) PORT SYSTEM FOR A PERCUTANEOUSLY IMPLANTED PORT
WO2002032283A3 (en) Methods of and pharmaceutical compositions for improving implantation of embryos
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2001283504A1 (en) Cell implantation therapy for neurological diseases or disorders
WO2000064422A3 (en) Novel treatment of neurotraumatic conditions with raf inhibitor
FR2815691B1 (en) VALVE BALL
WO2001030980A3 (en) Methods and compositions for enhancing developmental potential of oocytes and zygotes
ZA200104596B (en) IBDV strain for in ovo administration.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001978796

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001978796

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001978796

Country of ref document: EP